title: Probing the HIV gp120 envelope glycoprotein conformation by NMR.
abstract: The HIV envelope glycoprotein gp120 plays a critical role in virus entry, and thus, its structure is of extreme interest for the development of novel therapeutics and vaccines. To date, high resolution structural information about gp120 in complex with gp41 has proven intractable. In this study, we characterize the structural properties of gp120 in the presence and absence of gp41 domains by NMR. Using the peptide probe 12p1 (sequence, RINNIPWSEAMM), which was identified previously as an entry inhibitor that binds to gp120, we identify atoms of 12p1 in close contact with gp120 in the monomeric and trimeric states. Interestingly, the binding mode of 12p1 with gp120 is similar for clades B and C. In addition, we show a subtle difference in the binding mode of 12p1 in the presence of gp41 domains, i.e. the trimeric state, which we interpret as small differences in the gp120 structure in the presence of gp41.
authors: Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois 60607, USA.
authors: Jessica
authors: J
authors: Celigoy
authors: Benjamin
authors: B
authors: Ramirez
authors: Lin
authors: L
authors: Tao
authors: Lijun
authors: L
authors: Rong
authors: Lianying
authors: L
authors: Yan
authors: Yan-Ru
authors: YR
authors: Feng
authors: Gerald V
authors: GV
authors: Quinnan
authors: Christopher C
authors: CC
authors: Broder
authors: Michael
authors: M
authors: Caffrey
references: ChemMedChem. 2006 Jan;1(1):54-7
references: 16892335
references: Eur J Biochem. 2002 Oct;269(19):4860-7
references: 12354117
references: Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):1166-71
references: 20080564
references: J Am Chem Soc. 2008 Jun 11;130(23):7212-3
references: 18481853
references: J Med Chem. 2008 May 8;51(9):2638-47
references: 18402432
references: J Virol. 2002 May;76(9):4634-42
references: 11932429
references: J Virol. 2000 May;74(10):4746-54
references: 10775613
references: Annu Rev Biochem. 2001;70:777-810
references: 11395423
references: Biochemistry. 2004 Feb 24;43(7):1928-38
references: 14967033
references: J Biol Chem. 2008 Nov 21;283(47):32644-9
references: 18815131
references: Biochemistry. 2008 Jul 29;47(30):7788-95
references: 18597484
references: J Mol Biol. 1997 Sep 5;271(5):819-26
references: 9299329
references: Trends Microbiol. 2011 Apr;19(4):191-7
references: 21377881
references: EMBO J. 1998 Aug 17;17(16):4572-84
references: 9707417
references: Cell. 1997 Apr 18;89(2):263-73
references: 9108481
references: J Biomol NMR. 2000 Sep;18(1):43-8
references: 11061227
references: J Biomol NMR. 1995 Nov;6(3):277-93
references: 8520220
references: J Virol. 1999 Jul;73(7):5795-802
references: 10364331
references: J Virol. 2000 Jan;74(2):627-43
references: 10623724
references: Nature. 1998 Jun 18;393(6686):648-59
references: 9641677
references: Biochim Biophys Acta. 2001 May 31;1536(2-3):116-22
references: 11406346
references: Retrovirology. 2010 Nov 04;7:92
references: 21050445
references: Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10193-8
references: 17540729
references: Nature. 1997 May 22;387(6631):426-30
references: 9163431
references: Nat Struct Mol Biol. 2008 Jul;15(7):690-8
references: 18596815
references: J Mol Biol. 1997 Oct 17;273(1):122-49
references: 9367752
references: J Biol Chem. 2003 May 30;278(22):19587-90
references: 12679331
references: Angew Chem Int Ed Engl. 2003 Feb 24;42(8):864-90
references: 12596167
references: Nature. 2005 Feb 24;433(7028):834-41
references: 15729334
references: Biochim Biophys Acta. 2003 Jul 11;1614(1):36-50
references: 12873764
references: Angew Chem Int Ed Engl. 2008;47(10):1910-2
references: 18232036
references: Curr Opin Struct Biol. 2007 Apr;17(2):244-52
references: 17395457